These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24347181)

  • 1. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer's disease.
    Cong L; Jia J; Qin W; Ren Y; Sun Y
    Acta Neurol Belg; 2014 Sep; 114(3):195-206. PubMed ID: 24347181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line.
    Sung HY; Choi EN; Ahn Jo S; Oh S; Ahn JH
    Biochem Biophys Res Commun; 2011 Nov; 414(4):700-5. PubMed ID: 22001921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
    Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
    Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid Beta-Mediated Hypomethylation of Heme Oxygenase 1 Correlates with Cognitive Impairment in Alzheimer's Disease.
    Sung HY; Choi BO; Jeong JH; Kong KA; Hwang J; Ahn JH
    PLoS One; 2016; 11(4):e0153156. PubMed ID: 27058954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the APP/PS1 mouse model of Alzheimer's disease in senescence accelerated background.
    Lok K; Zhao H; Shen H; Wang Z; Gao X; Zhao W; Yin M
    Neurosci Lett; 2013 Dec; 557 Pt B():84-9. PubMed ID: 24176881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex.
    Bakulski KM; Dolinoy DC; Sartor MA; Paulson HL; Konen JR; Lieberman AP; Albin RL; Hu H; Rozek LS
    J Alzheimers Dis; 2012; 29(3):571-88. PubMed ID: 22451312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyroglutamate-modified amyloid-β protein demonstrates similar properties in an Alzheimer's disease familial mutant knock-in mouse and Alzheimer's disease brain.
    Wu G; Miller RA; Connolly B; Marcus J; Renger J; Savage MJ
    Neurodegener Dis; 2014; 14(2):53-66. PubMed ID: 24158021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
    Cadena-del-Castillo C; Valdes-Quezada C; Carmona-Aldana F; Arias C; Bermúdez-Rattoni F; Recillas-Targa F
    J Alzheimers Dis; 2014; 41(3):845-54. PubMed ID: 24685633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional metabolic alteration of Alzheimer's disease in mouse brain expressing mutant human APP-PS1 by 1H HR-MAS.
    Woo DC; Lee SH; Lee DW; Kim SY; Kim GY; Rhim HS; Choi CB; Kim HY; Lee CU; Choe BY
    Behav Brain Res; 2010 Jul; 211(1):125-31. PubMed ID: 20307581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
    Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
    Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
    Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid administration inhibits amyloid β-peptide accumulation in APP/PS1 transgenic mice.
    Li W; Liu H; Yu M; Zhang X; Zhang M; Wilson JX; Huang G
    J Nutr Biochem; 2015 Aug; 26(8):883-91. PubMed ID: 25959374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.
    Jaffar S; Counts SE; Ma SY; Dadko E; Gordon MN; Morgan D; Mufson EJ
    Exp Neurol; 2001 Aug; 170(2):227-43. PubMed ID: 11476589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
    Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
    Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.